Related references
Note: Only part of the references are listed.Aspirin for the Prevention of Cardiovascular Disease: U.S. Preventive Services Task Force Recommendation Statement
ANNALS OF INTERNAL MEDICINE (2013)
Review: Daily aspirin reduces short-term risk for cancer and cancer mortality
Andrew K. Diehl
ANNALS OF INTERNAL MEDICINE (2012)
Aspirin and Cancer Prevention and Treatment: Are We There Yet?
John D. Potter
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Non-aspirin Non-steroidal Anti-inflammatory Drugs for the Primary Chemoprevention of Non-gastrointestinal Cancer: Summary of Evidence
Marcus Tolentino Silva et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Nonsteroidal Anti-inflammatory Drug Use, Chronic Liver Disease, and Hepatocellular Carcinoma
Vikrant V. Sahasrabuddhe et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials
Peter M. Rothwell et al.
LANCET (2012)
Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials
Peter M. Rothwell et al.
LANCET (2012)
Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
Annemijn M. Algra et al.
LANCET ONCOLOGY (2012)
Aspirin and non-aspirin non-steroidal anti-inflammatory drug use and risk of lung cancer
Wei-Yen Lim et al.
LUNG CANCER (2012)
Aspirin for the prevention of colorectal cancer
X. Garcia-Albeniz et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2011)
Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study
Aditya Bardia et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Aspirin for prevention of cancer and cardiovascular disease
Peter W. Rose et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2011)
Regular aspirin use and breast cancer risk in US Black Women
Jaclyn L. F. Bosco et al.
CANCER CAUSES & CONTROL (2011)
Aspirin, Nonsteroidal Anti-inflammatory Drugs, Acetaminophen, and Pancreatic Cancer Risk: a Clinic-Based Case-Control Study
Xiang-Lin Tan et al.
CANCER PREVENTION RESEARCH (2011)
Associations of aspirin, nonsteroidal anti-inflammatory drug and paracetamol use with PSA-detected prostate cancer: findings from a large, population-based, case-control study (the ProtecT study)
Ali S. Murad et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis
Sven Trelle et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Use of Aspirin and Other Nonsteroidal Antiinflammatory Medications in Relation to Prostate Cancer Risk
Claudia A. Salinas et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
A Prospective Study of Aspirin Use and the Risk of Gastrointestinal Bleeding in Men
Edward S. Huang et al.
PLOS ONE (2010)
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
LANCET (2009)
Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease
Christianne L. Roumie et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
Management of Patients on Nonsteroidal Anti-inflammatory Drugs: A Clinical Practice Recommendation From the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents
Francis K. L. Chan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Nonselective and Cyclooxygenase-2-Selective NSAIDs and Acute Kidney Injury
Wolfgang C. Winkelmayer et al.
AMERICAN JOURNAL OF MEDICINE (2008)
Recommendations for use of selective and nonselective nonsteroidal antiinflammatory drugs: An American College of Rheumatology white paper
Sonali P. Desai et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of cancers of the esophagus
Shahram Sadeghi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Aspirin dose and duration of use and risk of colorectal cancer in men
Andrew T. Chan et al.
GASTROENTEROLOGY (2008)
ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents
Deepak L. Bhatt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Use of NSAIDs, smoking and lung cancer risk
J. H. Olsen et al.
BRITISH JOURNAL OF CANCER (2008)
Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers
Joan Fortuny et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: US preventive services task force recommendation statement
ANNALS OF INTERNAL MEDICINE (2007)
Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: A systematic review prepared for the US Preventive Services Task Force
Alaa Rostom et al.
ANNALS OF INTERNAL MEDICINE (2007)
The use of aspirin for primary prevention of colorectal cancer: A systematic review prepared for the US Preventive Services Task Force
Catherine Dube et al.
ANNALS OF INTERNAL MEDICINE (2007)
Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs:: does their cardiovascular risk exceed their gastrointestinal benefit?: A retrospective cohort study
E. Rahme et al.
RHEUMATOLOGY (2007)
Gender differences in aspirin use among adults with coronary heart disease in the United States
Alexander R. Opotowsky et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2007)
Aspirin and nonsteroidal anti-inflammatory drug use and risk of pancreatic cancer: A meta-analysis
Susanna C. Larsson et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Cardiovascular risk and inhibition of cyclooxygenase - A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase
Patricia McGettigan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events - Meta-analysis of randomized trials
Jingjing Zhang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials
Patricia M. Kearney et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer
AT Chan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Frequent monthly use of selected non-prescription and prescription non-narcotic analgesics among US adults
R Paulose-Ram et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2005)
A prospective study of aspirin use and the risk of pancreatic cancer in women
ES Schernhammer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Consumption of NSAIDs and the development of congestive heart failure in elderly patients -: An underrecognized public health problem
J Page et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
